Strides Pharma Science Share Price Jumps to Fresh 52-Week High at Rs 1,242: Here’s Why
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Strides Pharma Science Share Price was in focus after STAR rose to Rs 1,236.50, up 1.35% from the previous close of Rs 1,220, and touched a fresh 52-week high of Rs 1,242.40. The company’s market capitalisation stood at Rs 11,245.07 crore. The move makes Strides Pharma Science Share Price a notable part of today’s Indian stock market discussion, especially for readers tracking Strides Pharma Science Share Price Today and Strides Pharma Science Stock News.
The day’s range was tight, with the stock opening at Rs 1,211.20 and later reaching Rs 1,242.40, which also marked the day high and the 52-week high. The supplied data confirms the price event but does not establish a company-specific catalyst. Turnover for the session stood at Rs 0.43 crore, which is a factual traded-value metric. For investors following Strides Pharma Science Share Price Live, the key point is simple: the stock has printed a fresh yearly high and is now being watched for how the next sessions build on that price action.
Univest tracks such market moves with a focus on verified price data, valuation context and company fundamentals. In this case, Strides Pharma Science Share Price news is shaped by the fresh 52-week high, the 1.35% rise, and the company’s Rs 11,245.07 crore market cap. That makes the stock relevant not only for short-listing in stocks in news, but also for readers looking for Strides Pharma Science Share Price Update and Strides Pharma Science Latest News.
Strides Pharma Science Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,236.5 |
| Previous Close | Rs 1,220 |
| Today's Move | +Rs 16.5 (+1.35%) |
| Open | Rs 1,211.2 |
| High | Rs 1,242.4 |
| Low | Rs 1,211.2 |
| Turnover | Rs 0.43 crore |
| Market Capitalisation | Rs 11,245.07 crore |
Strides Pharma Science Ltd. (STAR) traded at Rs 1,236.5 versus the previous close of Rs 1,220, a rise of 1.35%. The stock opened at Rs 1,211.2, reached a high of Rs 1,242.4 and touched a low of Rs 1,211.2.
Strides Pharma Science Share Price Today shows a clear move above the previous close, with the stock ending at Rs 1,236.50 versus Rs 1,220 on the prior session. The absolute gain was Rs 16.50, or 1.35%, and the day’s high of Rs 1,242.40 matched the fresh 52-week high. The low and open were both Rs 1,211.20, so the stock traded within a narrow band around the opening level before extending to the yearly high.
From a market-news perspective, this is the central event: Strides Pharma Science Share Price has reached a fresh 52-week high on verified figures, without any additional company-specific explanation in the supplied data. That is why the move enters the discussion on Strides Pharma Science Share News, Strides Pharma Science Stock News and Strides Pharma Science Share Price Update. The turnover of Rs 0.43 crore adds a factual session marker, but it should be read only as turnover, not as a comment on participation or demand.
Because the current price, previous close, open, low and high are all known, the day’s structure is easy to read. The stock opened below the eventual peak, held above the low, and completed the session at a level close to the high. For readers tracking Strides Pharma Science Share Price and Strides Pharma Science Share Price Today, the fresh 52-week high is the relevant event to note before moving to fundamentals and sector context.
Strides Pharma Science Ltd. (STAR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 11,245.07 crore |
| P/E Ratio | 18.33x |
| P/B Ratio | 3.43x |
| ROE | 20.31% |
| ROCE | 18.57% |
| EPS | Rs 66.56 |
| Book Value Per Share | Rs 355.18 |
| Dividend Yield | 0.41% |
Strides Pharma Science Ltd. (STAR) fundamental metrics show P/E 18.33x, P/B 3.43x, ROE 20.31%, ROCE 18.57%. These figures provide context only and are not a buy or sell signal.
Strides Pharma Science Ltd. has a market capitalisation of Rs 11245.07 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 18.33x, P/B at 3.43x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.31% and ROCE of 18.57%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 66.56, book value per share of Rs 355.18, dividend yield of 0.41%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.9x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 18.33x |
| Benchmark Median P/E | 32.9x |
| Benchmark Average P/E | 48.96x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 3.43x |
| Benchmark Median P/B | 3.04x |
| Company ROE | 20.31% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 18.57% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 11,245.07 crore |
| Benchmark Median Market Cap | Rs 677.56 crore |
Strides Pharma Science Ltd. (STAR) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Strides Pharma Science Ltd. (STAR) has a P/E ratio of 18.33x, which is below the benchmark median of 32.9x, a difference of -44.29%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Strides Pharma Science Ltd. (STAR) has a ROE of 20.31%, which is above the benchmark median of 11.69%, a difference of +73.74%. Strides Pharma Science Ltd. (STAR) has a ROCE of 18.57%, which is above the benchmark median of 13.32%, a difference of +39.41%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sequent Scientific Ltd. | VIYASH | 11,036.28 | 64.48 | 3.92 | 9.06 | 13.1 |
| Blue Jet Healthcare Ltd. | BLUEJET | 10,887.14 | 46.35 | 4.86 | 19.88 | 27.18 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | 12,338.9 | 42.3 | 3.61 | 8.06 | 14.77 |
| Sudeep Pharma Ltd. | SUDEEPPHRM | 13,045 | 71.43 | 14.12 | 25.37 | 28.5 |
| CORONA Remedies Ltd. | CORONA | 13,447.57 | 67.57 | 16.66 | 27.36 | 31.74 |
Strides Pharma Science Ltd. (STAR) has a P/E ratio of 18.33x compared with the displayed peer median of 64.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.31% compares with a peer median of 19.88% across the companies shown in the table. ROCE stood at 18.57% versus the displayed peer median of 27.18%, providing a capital-efficiency comparison. Strides Pharma Science Ltd. (STAR) has a market capitalisation of Rs 11,245.07 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Strides Pharma Science
- Strides Pharma Science Share Price touched a fresh 52-week high of Rs 1,242.40.
- The stock finished at Rs 1,236.50, up Rs 16.50 or 1.35% from the previous close.
- Market capitalisation stood at Rs 11,245.07 crore.
- P/E was 18.33, below the same-industry median of 32.90.
- ROE of 20.31% and ROCE of 18.57% were both above the same-industry median levels.
About Strides Pharma Science
Strides Pharma Science Ltd. is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile data here is limited to that classification and the listed financial and market metrics used throughout this article. For readers tracking Strides Pharma Science Share Price, that means the most reliable context available in this note comes from the price event, the valuation ratios, the profitability metrics and the sector benchmark data. Univest uses only the verified fields supplied in the workflow, keeping the discussion factual and bounded by the available record.
Track Strides Pharma Science Share Price on Univest
Use Strides Pharma Science Ltd. (STAR) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Readers can track Strides Pharma Science Share Price on Univest for live price updates, share price news, valuation ratios, shareholding pattern, 52-week levels, market capitalisation and company insights. Univest brings together Strides Pharma Science Share Price Today, Strides Pharma Science Stock News and Strides Pharma Science Fundamental Analysis in one place for easier monitoring.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Strides Pharma Science Share Price today?
Ans. Strides Pharma Science Share Price today was Rs 1,236.50, up Rs 16.50 or 1.35% from the previous close of Rs 1,220. The session also marked a fresh 52-week high at Rs 1,242.40.
Did Strides Pharma Science hit a 52-week high?
Ans. Yes. Strides Pharma Science touched a fresh 52-week high of Rs 1,242.40. The stock opened at Rs 1,211.20 and closed at Rs 1,236.50, leaving the yearly high as the main event.
What is the market capitalisation of Strides Pharma Science?
Ans. Strides Pharma Science has a market capitalisation of Rs 11,245.07 crore. This places the company above the same-industry median market cap of Rs 677.56 crore in the supplied benchmark set.
How is Strides Pharma Science valued on P/E?
Ans. The company’s P/E ratio is 18.33. That is below the same-industry median of 32.90 and below the average of 48.96, which provides useful context for Strides Pharma Science Share Price.
What do ROE and ROCE show for Strides Pharma Science?
Ans. ROE is 20.31% and ROCE is 18.57%. Both measures are above the supplied industry medians of 11.69% and 13.32%, respectively, which adds important fundamental context. ROE stands at 20.31%. ROCE stands at 18.57%.
What are the EPS and book value for Strides Pharma Science?
Ans. EPS is Rs 66.56 and book value is Rs 355.18 per share. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
How does Strides Pharma Science compare with peers?
Ans. Compared with the supplied peers, Strides Pharma Science has a lower P/E than all five listed comparables and a market cap within the same broad band as several of them. That makes peer comparison useful here.
Which sector and industry does Strides Pharma Science belong to?
Ans. Strides Pharma Science belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The benchmark set supplied for the same industry includes 203 companies, which helps frame valuation comparisons.
Where can I track Strides Pharma Science Share Price?
Ans. You can track Strides Pharma Science Share Price on Univest for live price updates, shareholding pattern, valuation ratios, market capitalisation and 52-week levels. The platform keeps the company data in one place for quick review.
